{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:07:40Z","timestamp":1789765660905,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.cardfail.2008.02.006","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T10:35:26Z","timestamp":1212057326000},"page":"414-419","source":"Crossref","is-referenced-by-count":31,"title":["Variables Associated With Contrast-Enhanced Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy: Clinical Implications"],"prefix":"10.1016","volume":"14","author":[{"given":"Eduardo","family":"Pay\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ram\u00f3n","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo\u00edsa","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ruiz-Espejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"de la Morena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Vald\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2008.02.006_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/hrt.44.4.433","article-title":"Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis","volume":"44","author":"St John Sutton","year":"1980","journal-title":"Br Heart J"},{"key":"10.1016\/j.cardfail.2008.02.006_bib2","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","article-title":"The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"43","author":"Moon","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0735-1097(03)00189-X","article-title":"Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance","volume":"41","author":"Moon","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/01.RES.0000046234.73401.70","article-title":"Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases","volume":"91","author":"Tsuruda","year":"2002","journal-title":"Cir Res"},{"key":"10.1016\/j.cardfail.2008.02.006_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/hrt.77.2.130","article-title":"Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families","volume":"77","author":"McKenna","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2008.02.006_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1540-8159.1997.tb06206.x","article-title":"Hypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death","volume":"20","author":"Fananapazir","year":"1997","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib7","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy","volume":"324","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2008.02.006_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2008.02.006_bib9","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1161\/01.CIR.96.9.2987","article-title":"Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy","volume":"96","author":"Sadoul","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2008.02.006_bib10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.CIR.0000083233.86078.3E","article-title":"Clinical use of cardiovascular magnetic resonance","volume":"108","author":"Pohost","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2008.02.006_bib12","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.CIR.100.19.1992","article-title":"Relation of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function","volume":"100","author":"Kim","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2008.02.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0300-8932(07)74976-X","article-title":"What is late gadolinium enhancement in hypertrophic cardiomyopathy?","volume":"60","author":"Moon","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib14","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease","volume":"24","author":"Moon","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2008.02.006_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/10976640600605002","article-title":"The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease","volume":"8","author":"Moon","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cardfail.2008.02.006_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2214\/ajr.180.4.1800981","article-title":"Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging","volume":"180","author":"Bogaert","year":"2003","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib17","first-page":"176","article-title":"Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"29","author":"Wilson","year":"2002","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.cardfail.2008.02.006_bib18","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/S0735-1097(02)02602-5","article-title":"Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy","volume":"40","author":"Choudhury","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mri.2003.08.009","article-title":"Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy","volume":"22","author":"Teraoka","year":"2004","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.cardfail.2008.02.006_bib20","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/hrt.2005.079392","article-title":"Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis","volume":"92","author":"Debl","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2008.02.006_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1157\/13097920","article-title":"Detection and quantification of myocardial fibrosis in hypertrophic cardiomyopathy by contrast-enhanced cardiovascular magnetic resonance","volume":"60","author":"Pujadas","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1157\/13097921","article-title":"Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy","volume":"60","author":"Dumont","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00004728-200605000-00011","article-title":"Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular perfusion and contractile function","volume":"30","author":"Soler","year":"2006","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.cardfail.2008.02.006_bib24","first-page":"143","article-title":"Sudden cardiac death in patients with chronic coronary heart disease","volume":"85","author":"Hurwitz","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2008.02.006_bib25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cardfail.2007.02.001","article-title":"Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy","volume":"13","author":"Matoh","year":"2007","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.cardfail.2008.02.006_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.amjcard.2006.02.057","article-title":"Usefulness of N-terminal Pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy","volume":"98","author":"Thaman","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib27","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ahj.2005.02.045","article-title":"Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy","volume":"150","author":"Arteaga","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2008.02.006_bib28","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000117098.75727.D8","article-title":"Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy","volume":"109","author":"Maron","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2008.02.006_bib29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cardfail.2007.01.011","article-title":"Increased brain natriuretic peptide secretion is a marker of disease progression in nonobstructive hypertrophic cardiomyopathy","volume":"13","author":"Pieroni","year":"2007","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.cardfail.2008.02.006_bib30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ejheart.2003.11.012","article-title":"The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction","volume":"6","author":"Cochet","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2008.02.006_bib31","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2005.11.030","article-title":"Relation of B-type natriuretic peptide early after acute myocardial infarction to left ventricular diastolic function and extent of myocardial damage determined by magnetic resonance imaging","volume":"97","author":"Paelick","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/01.RES.0000117070.86556.9F","article-title":"B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation","volume":"94","author":"Kapoun","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2008.02.006_bib33","unstructured":"Rold\u00e1n V, Mar\u00edn F, Gimeno JR, Ruiz-Espejo F, Gonz\u00e1lez J, Feli\u00fa E, et\u00a0al. Matrix metalloproteinases and tissue remodelling in hypertrophic cardiomyopathy. Am Heart J. In press."},{"key":"10.1016\/j.cardfail.2008.02.006_bib34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0038-1653821","article-title":"Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the\u00a0ECAT Angina Pectoris Study Group","volume":"73","author":"Haverkate","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cardfail.2008.02.006_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.amjcard.2006.07.059","article-title":"Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris","volume":"99","author":"Gach","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib36","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.amjcard.2006.03.046","article-title":"Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure","volume":"98","author":"May","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2008.02.006_bib37","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/eurheartj\/ehl407","article-title":"Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure","volume":"27","author":"Siirila-Waris","year":"2006","journal-title":"Eur Heart J"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916408000614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916408000614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:40:30Z","timestamp":1588725630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916408000614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1071916408000614"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2008.02.006","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}